121 related articles for article (PubMed ID: 8706280)
1. Assessment of cure after transsphenoidal surgery for Cushing's disease.
McCance DR; Besser M; Atkinson AB
Clin Endocrinol (Oxf); 1996 Jan; 44(1):1-6. PubMed ID: 8706280
[TBL] [Abstract][Full Text] [Related]
2. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
[TBL] [Abstract][Full Text] [Related]
3. Assessment of endocrine function after transsphenoidal surgery for Cushing's disease.
McCance DR; Gordon DS; Fannin TF; Hadden DR; Kennedy L; Sheridan B; Atkinson AB
Clin Endocrinol (Oxf); 1993 Jan; 38(1):79-86. PubMed ID: 8382119
[TBL] [Abstract][Full Text] [Related]
4. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
Yap LB; Turner HE; Adams CB; Wass JA
Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
[TBL] [Abstract][Full Text] [Related]
5. Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?
Chee GH; Mathias DB; James RA; Kendall-Taylor P
Clin Endocrinol (Oxf); 2001 May; 54(5):617-26. PubMed ID: 11380492
[TBL] [Abstract][Full Text] [Related]
6. Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment.
Trainer PJ; Lawrie HS; Verhelst J; Howlett TA; Lowe DG; Grossman AB; Savage MO; Afshar F; Besser GM
Clin Endocrinol (Oxf); 1993 Jan; 38(1):73-8. PubMed ID: 8435888
[TBL] [Abstract][Full Text] [Related]
7. Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease.
van Aken MO; de Herder WW; van der Lely AJ; de Jong FH; Lamberts SW
Clin Endocrinol (Oxf); 1997 Aug; 47(2):145-9. PubMed ID: 9302385
[TBL] [Abstract][Full Text] [Related]
8. Predicting relapse after transsphenoidal surgery for Cushing's disease.
Toms GC; McCarthy MI; Niven MJ; Orteu CH; King TT; Monson JP
J Clin Endocrinol Metab; 1993 Feb; 76(2):291-4. PubMed ID: 8432771
[TBL] [Abstract][Full Text] [Related]
9. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
[TBL] [Abstract][Full Text] [Related]
10. A critical evaluation of transsphenoidal pituitary surgery in the treatment of Cushing's disease: prediction of outcome.
Arnott RD; Pestell RG; McKelvie PA; Henderson JK; McNeill PM; Alford FP
Acta Endocrinol (Copenh); 1990 Oct; 123(4):423-30. PubMed ID: 2173325
[TBL] [Abstract][Full Text] [Related]
11. Peri-operative management of Cushing's disease.
AbdelMannan D; Selman WR; Arafah BM
Rev Endocr Metab Disord; 2010 Jun; 11(2):127-34. PubMed ID: 20556520
[TBL] [Abstract][Full Text] [Related]
12. Cyclic Cushing's syndrome combined with cortisol suppressible, dexamethasone non-suppressible ACTH secretion: a new variant of Cushing's syndrome.
Schweikert HU; Fehm HL; Fahlbusch R; Martin R; Kolloch R; Higuchi M; Krück F
Acta Endocrinol (Copenh); 1985 Nov; 110(3):289-95. PubMed ID: 3000118
[TBL] [Abstract][Full Text] [Related]
13. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Cushing's disease by transsphenoidal, pituitary microsurgery: prognosis factors and long-term follow-up.
Bakiri F; Tatai S; Aouali R; Semrouni M; Derome P; Chitour F; Benmiloud M
J Endocrinol Invest; 1996 Oct; 19(9):572-80. PubMed ID: 8957739
[TBL] [Abstract][Full Text] [Related]
15. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
[TBL] [Abstract][Full Text] [Related]
16. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
[TBL] [Abstract][Full Text] [Related]
17. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease.
Estrada J; Boronat M; Mielgo M; Magallón R; Millan I; Díez S; Lucas T; Barceló B
N Engl J Med; 1997 Jan; 336(3):172-7. PubMed ID: 8988897
[TBL] [Abstract][Full Text] [Related]
18. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
Acebes JJ; Martino J; Masuet C; Montanya E; Soler J
Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome in children and adolescents after transsphenoidal surgery for Cushing's disease.
Devoe DJ; Miller WL; Conte FA; Kaplan SL; Grumbach MM; Rosenthal SM; Wilson CB; Gitelman SE
J Clin Endocrinol Metab; 1997 Oct; 82(10):3196-202. PubMed ID: 9329338
[TBL] [Abstract][Full Text] [Related]
20. [Transsphenoidal hypophysectomy of a patient with an ACTH-producing pituitary adenoma and an "empty sella" after pretreatment with etomidate].
Herrmann BL; Mitchell A; Saller B; Stolke D; Forsting M; Frilling A; Mann K
Dtsch Med Wochenschr; 2001 Mar; 126(9):232-4. PubMed ID: 11256037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
